Inhibitory effects of the ultrasound-targeted microbubble destruction-mediated herpes simplex virus-thymidine kinase/ganciclovir system on ovarian cancer in mice

被引:17
|
作者
Zhou, Xian-Long [1 ]
Shi, Yu-Lu [2 ]
Li, Xiong [3 ]
机构
[1] Wuhan Univ, Zhongnan Hosp, Emergency Ctr, Wuhan 430071, Hubei, Peoples R China
[2] Wuhan Univ, Med Coll, Wuhan 430072, Hubei, Peoples R China
[3] Wuhan Univ, Zhongnan Hosp, Dept Ultrasound, Wuhan 430071, Hubei, Peoples R China
关键词
ultrasound; gene therapy; ovarian cancer; herpes simplex virus-thymidine kinase; microbubbles; SUICIDE GENE-THERAPY; GLIOBLASTOMA-MULTIFORME; KINASE; GANCICLOVIR; DELIVERY; LIVER; RISK;
D O I
10.3892/etm.2014.1877
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The aim of the present study was to investigate the effect of the ultrasound-targeted microbubble destruction mediated (UTMD) herpes simplex virus-thymidine kinase (HSV-TK) and ganciclovir (GCV) system on ovarian cancer (OC). This study was conducted between June and December 2012 in the Animal Biosafety Level III Laboratory of Wuhan University. Mice with OC were randomly divided into four groups: i) HSV-TK plus microbubbles (MBs) plus ultrasound (US) (n=15); ii) HSV-TK plus US (n=15); iii) HSV-TK (n=15); and iv) phosphate-buffered saline (n=15). The inhibitory effect and survival time in the experimental groups were compared with those in the control group. The TK protein expression was detected by western blot analysis. Tumor cell apoptosis was detected by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling and caspase-3 activity analysis. The data showed that the efficiency of HSV-TK gene transfection and the tumor inhibitory effects were significantly increased in the HSV-TK plus MBs plus US group compared with those in the control group (P<0.01). UTMD-mediated HSV-TK treatment has also improved the rat survival rate (P<0.01). In conclusion, UTMD can effectively transfect the HSV-TK gene into target tissues and exert a significant inhibitory effect on OC in mice.
引用
收藏
页码:1159 / 1163
页数:5
相关论文
共 50 条
  • [21] Co-expression of bfl-1 enhances host response in the herpes simplex virus-thymidine kinase/ganciclovir gene therapy system
    Kwon, GY
    Jeong, J
    Woo, JK
    Choi, HY
    Lee, MJ
    Ko, JK
    Shim, YH
    Kim, CW
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 303 (03) : 756 - 763
  • [22] Effects of bicistronic lentiviral vector-mediated herpes simplex virus thymidine kinase/ganciclovir system on human lens epithelial cells
    Yang, Jin
    Liu, Tian An
    Lu, Yi
    CURRENT EYE RESEARCH, 2007, 32 (01) : 33 - 42
  • [23] Ultrasound-Targeted Microbubble Destruction-Mediated Downregulation of EZH2 Inhibits Stemness and Epithelial-Mesenchymal Transition of Liver Cancer Stem Cells
    Wu, Jie
    Sun, Lulu
    Liu, Tingting
    Dong, Gang
    ONCOTARGETS AND THERAPY, 2021, 14 : 221 - 237
  • [24] Ultrasound-targeted microbubble destruction-mediated downregulation of CD 133 inhibits epithelial-mesenchymal transition, sternness and migratory ability of liver cancer stem cells
    Liu, Yan-Min
    Li, Xuan-Fei
    Liu, Hao
    Wu, Xiao-Ling
    ONCOLOGY REPORTS, 2015, 34 (06) : 2977 - 2986
  • [25] Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir
    Rosenfeld, ME
    Feng, MZ
    Michael, SI
    Siegal, GP
    Alvarez, RD
    Curiel, DT
    CLINICAL CANCER RESEARCH, 1995, 1 (12) : 1571 - 1580
  • [26] (E)-5-(2-Bromovinyl)-2′-deoxyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase–expressing cells
    Wolfgang Hamel
    Dorothea Zirkel
    H. Maximilian Mehdorn
    Manfred Westphal
    Mark A Israel
    Cancer Gene Therapy, 2001, 8 : 388 - 396
  • [27] (E)-5-(2-bromovinyl)-2′-deosyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase-expressing cells
    Hamel, W
    Zirkel, D
    Mehdorn, HM
    Westphal, M
    Israel, MA
    CANCER GENE THERAPY, 2001, 8 (05) : 388 - 396
  • [28] Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer
    Hall, SJ
    Mutchnik, SE
    Yang, G
    Timme, TL
    Nasu, Y
    Bangma, CH
    Woo, SLC
    Shaker, M
    Thompson, TC
    CANCER GENE THERAPY, 1999, 6 (01) : 54 - 63
  • [29] Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer
    Simon J Hall
    Steven E Mutchnik
    Guang Yang
    Terry L Timme
    Yasutomo Nasu
    Chris H Bangma
    Savio L C Woo
    Mohammed Shaker
    Timothy C Thompson
    Cancer Gene Therapy, 1999, 6 : 54 - 63
  • [30] A phase I trial of in vivo gene therapy with the herpes simplex thymidine kinase ganciclovir system for the treatment of refractory or recurrent ovarian cancer
    Link, CJ
    Moorman, D
    Seregina, T
    Levy, JP
    Schabold, KJ
    HUMAN GENE THERAPY, 1996, 7 (09) : 1161 - 1179